-
41
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
Published 2025-02-01Subjects: Get full text
Article -
42
Small cell lung cancer with EML4-ALK fusion: report of a case responding to ALK TKI and literature review
Published 2025-02-01Subjects: Get full text
Article -
43
Harnessing amino acid pathways to influence myeloid cell function in tumor immunity
Published 2025-02-01Subjects: Get full text
Article -
44
Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins
Published 2025-02-01Subjects: Get full text
Article -
45
From detection to elimination: iron-based nanomaterials driving tumor imaging and advanced therapies
Published 2025-02-01Subjects: Get full text
Article -
46
Recent research progress on metal ions and metal-based nanomaterials in tumor therapy
Published 2025-02-01Subjects: Get full text
Article -
47
Editorial: Deciphering the regulatory role of transcription factors in cancer immune infiltration
Published 2025-02-01Subjects: Get full text
Article -
48
Profile of STING agonist and inhibitor research: a bibliometric analysis
Published 2025-02-01Subjects: Get full text
Article -
49
Mitochondria-targeted photothermal-chemodynamic therapy enhances checkpoint blockade immunotherapy on colon cancer
Published 2025-04-01Subjects: “…Checkpoint blockade immunotherapy…”
Get full text
Article -
50
-
51
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Subjects: Get full text
Article -
52
-
53
Unraveling the microbial mysteries: gut microbiota’s role in ulcerative colitis
Published 2025-02-01Subjects: Get full text
Article -
54
Editorial: Beyond PD-1: novel checkpoint receptors and ligands as targets for immunotherapy
Published 2025-02-01Subjects: “…ICI Immunotherapy…”
Get full text
Article -
55
-
56
-
57
Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
Published 2024-01-01Subjects: Get full text
Article -
58
Why PD-L1 expression varies between studies of lung cancer: results from a Bayesian meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
59
CD32B1, a versatile non-signaling antibody-binding scaffold for enhanced T cell adhesion to tumor stromal cognate antigens
Published 2025-02-01Subjects: “…cancer immunotherapy…”
Get full text
Article -
60
Bibliometric insight into neoadjuvant immunotherapy in non-small cell lung cancer: trends, collaborations, and future avenues
Published 2025-02-01Subjects: Get full text
Article